Neuronal differentiation and cell-cycle programs mediate response to BET-bromodomain inhibition in MYC-driven medulloblastomaPratiti Bandopadhayay, James M. Olson, Federica Piccioni et al.|Nature Communications|2019Cited by 60
The Folate Cycle Enzyme MTHFR Is a Critical Regulator of Cell Response to MYC-Targeting TherapiesAngela Su, Alexandre Puissant, Frank Ling et al.|Cancer Discovery|2020Cited by 26
Neuronal differentiation and cell-cycle programs mediate response to BET-bromodomain inhibition in MYC-driven medulloblastomaPratiti Bandopadhayay, James M. Olson, Federica Piccioni et al.|RePEc: Research Papers in Economics|2019Cited by 11
Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AMLMatteo Marchesini, Giovanni Roti|Nature Communications|2024Cited by 5
CAD204520 Targets NOTCH1 PEST Domain Mutations in Lymphoproliferative DisordersLuca Pagliaro, Giovanni Roti|International Journal of Molecular Sciences|2024Cited by 5